Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for iSpecimen Inc. (ISPC : NSDQ)

• Company Description    iSpecimen Inc. offers an online marketplace for human biospecimens, connecting life scientists in commercial and non-profit organizations with healthcare providers which have access to patients and specimens needed for medical discovery. iSpecimen Inc. is based in LEXINGTON, Mass. Number of Employees: 7

• Price / Volume Information    Yesterday's Closing Price: $3.45 Daily Weekly Monthly 20 Day Moving Average: 823,717 shares Shares Outstanding: 1.44 (millions) Market Capitalization: $4.96 (millions) Beta: 1.75 52 Week High: $103.20 52 Week Low: $3.20 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week -46.82% -49.42% 12 Week -68.64% -71.01% Year To Date -66.84% -68.45%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 8 CABOT ROAD SUITE 1800 - WOBURN,MA 01801 USA ph: 781-301-6700 fax: - info@ispecimen.com http://www.ispecimen.com

• General Corporate Information    Officers Katharyn Field - Chief Executive Officer; President; Treasurer and Yuying Liang - Chief Financial Officer Avtar Dhaliwal - Director Anthony Lau - Director Arphing Lee - Director Peer Information iSpecimen Inc. (CHCR) iSpecimen Inc. (ESRX) iSpecimen Inc. (MYDP) iSpecimen Inc. (COR) iSpecimen Inc. (GBCS) iSpecimen Inc. (LAXAF) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: Medical Services Sector: Medical CUSIP: 45032V306 SIC: 8731 Fiscal Year Fiscal Year End: December Last Reported Quarter: 03/01/26 Next Expected EPS Date: 08/13/26 Share - Related Items Shares Outstanding: 1.44 Most Recent Split Date: 4.00 (0.03:1) Beta: 1.75 Market Capitalization: $4.96 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $ Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $ Payout Ratio: Number of Estimates in the Fiscal Year Consensus: Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 08/13/26

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: 6.09 Price/Cash Flow: - Price / Sales: 4.82 EPS Growth vs. Year Ago Period: 76.55% vs. Previous Quarter: 77.50% Sales Growth vs. Year Ago Period: -85.26% vs. Previous Quarter: 200.00% ROE 03/31/26 - -584.65 12/31/25 - -496.31 09/30/25 - -531.78 ROA 03/31/26 - -142.48 12/31/25 - -133.56 09/30/25 - -147.74 Current Ratio 03/31/26 - 0.62 12/31/25 - 1.12 09/30/25 - 0.63 Quick Ratio 03/31/26 - - 12/31/25 - 1.12 09/30/25 - 0.63 Operating Margin 03/31/26 - -1,080.16 12/31/25 - -543.37 09/30/25 - -343.86 Net Margin 03/31/26 - -1,080.16 12/31/25 - -543.37 09/30/25 - -343.86 Pre-Tax Margin 03/31/26 - -1,080.25 12/31/25 - -543.70 09/30/25 - -343.86 Book Value 03/31/26 - 0.57 12/31/25 - 14.57 09/30/25 - 12.58 Inventory Turnover 03/31/26 - - 12/31/25 - - 09/30/25 - 233.30 Debt-to-Equity 03/31/26 - 0.00 12/31/25 - 0.00 09/30/25 - 0.00 Debt-to-Capital 03/31/26 - 0.00 12/31/25 - 0.00 09/30/25 - 0.00

Powered by Zacks Investment Research ©